Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3503544 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL586052 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL7538069 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL3503100 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL4401743 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL3503265 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27343249 | 1.00 | DGKA (0.64) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL536437 | 0.97 | DGKA (0.60) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL17637589 | 0.93 | DGKA (0.57) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL7057407 | 0.93 | ALDH1A1 (0.58) | DGKATSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371777-B | Epoxy resin condensate and preparation method thereof | 苏州大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119371777-A | Epoxy resin condensate and preparation method thereof | 苏州大学 | 2025-01-28 | — | — | CN | claimed |
| US-11603506-B2 | Product comprising a plastic container and a substance composition | SYMRISE AG (DE) | 2023-03-14 | — | — | US | claimed |
| US-20190225396-A1 | PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION | SYMRISE AG (DE) | 2019-07-25 | — | — | US | claimed |
| EP-3507352-A1 | PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION | Symrise AG (DE) | 2019-07-10 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| WO-2018041354-A1 | PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION | SYMRISE AG (DE) | 2018-03-08 | — | — | WO | claimed |
| EP-2020225-B1 | Fragrance composition | KAO CORP (JP) | 2014-10-08 | — | — | EP | claimed |
| EP-2020225-A2 | Fragrance composition | Kao Corporation (JP) | 2009-02-04 | — | — | EP | claimed |
| EP-1417372-B1 | FRAGRANCE COMPOSITIONS FOR CO2 DRY CLEANING PROCESS | SYMRISE GMBH & CO KG (DE) | 2006-09-27 | — | — | EP | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| EP-0975622-B1 | SELECTIVE OLEFIN METATHESIS OF BIFUNCTIONAL OR POLYFUNCTIONAL SUBSTRATES IN COMPRESSED CARBON DIOXIDE AS REACTION MEDIUM | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-10-09 | — | — | EP | claimed |
| EP-1037897-B1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-06-12 | — | — | EP | claimed |
| US-6348551-B1 | CATALYTIC CYCLIZATION OF ALKENES AND ALKYNES; ESTERIFICATION, LACTONIZATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-02-19 | — | — | US | claimed |
| US-6034052-A | CONTAINING DIESTERS | HAARMANN & REIMER GMBH (DE) | 2000-03-07 | — | — | US | claimed |
| US-5876492-A | Ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| EP-0260680-B1 | Improved process for the production of macrocyclic esters by the depolymerization of polyesters | HENKEL CORP (US) | 1993-10-27 | — | — | EP | claimed |
| EP-0260680-A2 | Improved process for the production of macrocyclic esters by the depolymerization of polyesters | HENKEL CORPORATION (US) | 1988-03-23 | — | — | EP | claimed |
| US-4709058-A | Process for the production of macrocyclic esters by the depolymerization of polyesters | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1987-11-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | DGKA 75/4885TSHR 4206/4885LMNA 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.